ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1127

Semiquantitative MRI Features Of Knee Osteoarthritis Show Compartment-Specific Relationships With Quantitative Cartilage Thickness Loss: The Multicenter Osteoarthritis Study

Ali Guermazi1, Felix Eckstein2, Daichi Hayashi3, Frank Roemer4, Wolfgang Wirth2, Tianzhong Yang5, Jingbo Niu6, Leena Sharma7, Michael C. Nevitt8, Cora E. Lewis9, James Torner10 and David T. Felson11, 1Boston University, Boston, MA, 2Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, 3Department of Radiology, Boston University School of Medicine, Boston, MA, 4Radiology, Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology, Boston University School of Medicine, Boston, MA, 6Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 7Northwestern University, Chicago, IL, 8Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 9Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 10Epidemiology, University of Iowa, Iowa City, Iowa City, IA, 11Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, Magnetic resonance imaging (MRI), osteoarthritis and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases II: Imaging in Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Structural progression of knee OA has been associated with several radiographic and MRI-measured pathological features of OA, including malalignment, meniscal pathology and bone marrow changes but studies examining these risk factors generally examine one of them and not their constellation although these features coexist. To date no study has been done to assess if baseline MRI-based scores of various knee OA features predict progression of knee OA as determined by quantitative cartilage thickness measurement. We aimed to determine which semiquantitative MRI-based OA features were most predictive of subsequent cartilage thickness loss measured with quantitative MRI.

Methods: From the Multicenter OA Study subcohort, participants (one knee per person) who volunteered for a longitudinal substudy in which MRI measurement of cartilage thickness and volume were done were selected: These subjects also had conventional MRI’s allowing Whole Organ MRI Score (WORMS) based scoring of cartilage lesions, bone marrow lesions (BML), meniscal pathology, effusion synovitis, and Hoffa synovitis at both time points. Progression in the medial or lateral femorotibial compartment (MFTC/LFTC) was defined as cartilage thickness loss exceeding the change observed in OAI control cohort knees (mean ± 2xSD, MFTC/LFTC: -162µm/-145µm). All MRI predictors were dichotomized into “present” (score≥2 for cartilage, ≥0 for others) or “absent”. Differences in baseline scores of ipsi-compartmental predictor variables were compared between progressor and non-progressor knees by multivariable logistic regression, adjusting for age, sex, body mass index, and anatomical alignment axis (degrees). We combined MFTC and LFTC to calculate ajusted odds ratio (aOR) and 95% CI of ipsi-compartmental cartilage thickness loss across compartments, using Generalized Estimating Equations. Also, ORs and 95%CIs were calculated for MFTC and LFTC cartilage thickness loss, separately.

Results: 196 participants were included and their mean age was 59.8±6.3 years, mean BMI 29.5±4.6 kg/m2, and 62% were women. 46 knees had radiographic knee OA at baseline. In the MFTC/LFTC, there were 35/29 progressors and 161/167 non-progressors. For analysis combining MFTC and LFTC, predictors of cartilage thickness loss were baseline cartilage lesions (aOR 2.6 [1.4-5.0]), BML (aOR 1.9 [1.1-3.3]), meniscal damage (aOR 4.5 [2.4-8.4]) and meniscal extrusion (aOR 3.3 [1.9-5.8]), all in the ipsilateral compartment, but not effusion synovitis or Hoffa synovitis. In MFTC-only analysis, MFTC progressors had higher aOR for having baseline medial meniscal damage (aOR 2.4, [95%CI 1.1-5.6]), medial meniscal extrusion (aOR 2.6 [1.1-5.8]), but not cartilage lesions, BML, effusion synovitis and Hoffa synovitis. In the LFTC-only analysis, baseline lateral cartilage lesions (aOR 3.4 [1.3-9.3]), lateral meniscal damage (aOR 13.9 [3.3-9.0]) and lateral meniscal extrusion (aOR5.0 [1.4-18.0]) predicted LFTC progression.

Conclusion: Amongst MRI features, the presence of cartilage lesions, BML, meniscal damage and extrusion in the ipsilateral FTC predict quantitatively assessed cartilage thickness loss over 30-months, but not effusion synovitis or Hoffa synovitis.


Disclosure:

A. Guermazi,

Boston Imaging Core Lab,

1,

Merck Serono,

5,

Sanofi-Aventis Pharmaceutical,

5,

TissueGene,

5;

F. Eckstein,

Chondrometrics GmbH,

4,

Merck Serono,

5,

Abbvie,

5;

D. Hayashi,
None;

F. Roemer,

Boston Imaging Core Lab, LLC,

1,

National Institute of Health,

5,

Merck Serono,

5;

W. Wirth,

Chondrometrics, GmbH,

4;

T. Yang,
None;

J. Niu,
None;

L. Sharma,
None;

M. C. Nevitt,
None;

C. E. Lewis,
None;

J. Torner,
None;

D. T. Felson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/semiquantitative-mri-features-of-knee-osteoarthritis-show-compartment-specific-relationships-with-quantitative-cartilage-thickness-loss-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology